Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021

Detalles Bibliográficos
Autores principales: Rosenblum, Hannah G., Hadler, Stephen C., Moulia, Danielle, Shimabukuro, Tom T., Su, John R., Tepper, Naomi K., Ess, Kevin C., Woo, Emily Jane, Mba-Jonas, Adamma, Alimchandani, Meghna, Nair, Narayan, Klein, Nicola P., Hanson, Kayla E., Markowitz, Lauri E., Wharton, Melinda, McNally, Veronica V., Romero, José R., Talbot, H. Keipp, Lee, Grace M., Daley, Matthew F., Mbaeyi, Sarah A., Oliver, Sara E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360272/
https://www.ncbi.nlm.nih.gov/pubmed/34383735
http://dx.doi.org/10.15585/mmwr.mm7032e4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360272/
https://www.ncbi.nlm.nih.gov/pubmed/34383735
http://dx.doi.org/10.15585/mmwr.mm7032e4

Ejemplares similares